LIF/STAT3/SOCS3 Signaling Pathway in Murine Bone Marrow Stromal Cells Suppresses Osteoblast Differentiation

被引:38
作者
Matsushita, Kenta [1 ]
Itoh, Shousaku [1 ]
Ikeda, Shun [1 ]
Yamamoto, Yumiko [1 ]
Yamauchi, Yukako [1 ]
Hayashi, Mikako [1 ]
机构
[1] Osaka Univ Grad Sch Dent, Dept Restorat Dent & Endodontol, Osaka 5650871, Japan
基金
日本学术振兴会;
关键词
OSTEOBLASTS; BONE MARROW STROMAL CELLS; CELL DIFFERENTIATION; CYTOKINE; SIGNAL TRANSDUCTION; LEUKEMIA-INHIBITORY FACTOR; OSTEOCLAST DIFFERENTIATION; STAT3; ACTIVATION; GENE-EXPRESSION; BETA-CATENIN; E-CADHERIN; RECEPTOR; INTERLEUKIN-6; FAMILY; BINDING;
D O I
10.1002/jcb.24777
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that belongs to the interleukin-6 family and is expressed by multiple tissue types. This study analyzed the effect of LIF on osteoblast differentiation using primary murine bone marrow stromal cells (BMSCs). Colony-forming unit-osteoblast formation by BMSCs was significantly suppressed by LIF treatment. To clarify the mechanism underlying the LIF suppressive effect on osteoblast differentiation, we analyzed the downstream signaling pathway of LIF. LIF/signal transducer and activator of transcription 3 (STAT3) signaling induces the expression of suppressor of cytokine signaling 3 (SOCS3). SOCS3 knockdown experiments have previously demonstrated that short-hairpin SOCS3-BMSCs reversed the LIF suppressive effect. Our results demonstrated that LIF suppresses osteoblast differentiation through the LIF/STAT3/SOCS3 signaling pathway. J. Cell. Biochem. 115: 1262-1268, 2014. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:1262 / 1268
页数:7
相关论文
共 48 条
  • [1] Leukemia-inhibitory factor - Neuroimmune modulator of endocrine function
    Auernhammer, CJ
    Melmed, S
    [J]. ENDOCRINE REVIEWS, 2000, 21 (03) : 313 - 345
  • [2] Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion
    Auernhammer, CJ
    Chesnokova, V
    Bousquet, C
    Melmed, S
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (07) : 954 - 961
  • [3] Wnt signaling: An embarrassment of receptors
    Bejsovec, A
    [J]. CURRENT BIOLOGY, 2000, 10 (24) : R919 - R922
  • [4] Postnatal skeletal stem cells
    Bianco, Paolo
    Kuznetsov, Sergei A.
    Riminucci, Mara
    Robey, Pamela Gehron
    [J]. ADULT STEM CELLS, 2006, 419 : 117 - 148
  • [5] Von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation
    Bonewald, LF
    Harris, SE
    Rosser, J
    Dallas, MR
    Dallas, SL
    Camacho, NP
    Boyan, B
    Boskey, A
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2003, 72 (05) : 537 - 547
  • [6] Osteoclast differentiation and activation
    Boyle, WJ
    Simonet, WS
    Lacey, DL
    [J]. NATURE, 2003, 423 (6937) : 337 - 342
  • [7] THE EFFECT OF LEUKEMIA INHIBITORY FACTOR ON BONE INVIVO
    CORNISH, J
    CALLON, K
    KING, A
    EDGAR, S
    REID, IR
    [J]. ENDOCRINOLOGY, 1993, 132 (03) : 1359 - 1366
  • [8] A new protein containing an SH2 domain that inhibits JAK kinases
    Endo, TA
    Masuhara, M
    Yokouchi, M
    Suzuki, R
    Sakamoto, H
    Mitsui, K
    Matsumoto, A
    Tanimura, S
    Ohtsubo, M
    Misawa, H
    Miyazaki, T
    Leonor, N
    Taniguchi, T
    Fujita, T
    Kanakura, Y
    Komiya, S
    Yoshimura, A
    [J]. NATURE, 1997, 387 (6636) : 921 - 924
  • [9] LIF inhibits osteoblast differentiation at least in part by regulation of HAS2 and its product hyaluronan
    Falconi, Dominic
    Aubin, Jane E.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (08) : 1289 - 1300
  • [10] Leukemia inhibitory factor influences the fate choice of mesenchymal progenitor cells
    Falconi, Dominic
    Oizumi, Kiyoshi
    Aubin, Jane E.
    [J]. STEM CELLS, 2007, 25 (02) : 305 - 312